Larry LaMotte
[BLOG]: FDA approves first biosimilar in US, may lead to easier access to biologic medications for patients
In this guest blog post, Larry LaMotte, spokesperson for Patients for Biologics Safety & Access and Vice President of Public Policy at the Immune Deficiency Foundation, discusses the possibility of biosimilars helping increase access to vital medications for patients with chronic and life-threatening conditions.

Poll

View Results